{"name": "Talima Therapeutics",
 "permalink": "talima-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/talima-therapeutics",
 "homepage_url": "http://www.talima.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@talima.com",
 "phone_number": "650.331.7246",
 "description": "drug delivery company",
 "created_at": "Sat Sep 12 07:50:12 UTC 2009",
 "updated_at": "Wed Sep 01 12:47:50 UTC 2010",
 "overview": "\u003Cp\u003ETalima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. \u003C/p\u003E\n\n\u003Cp\u003EOur lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[136,
       65],
      "assets/images/resized/0005/9562/59562v1-max-150x150.jpg"],
     [[136,
       65],
      "assets/images/resized/0005/9562/59562v1-max-250x250.jpg"],
     [[136,
       65],
      "assets/images/resized/0005/9562/59562v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$21M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://venturebeat.com/2007/05/29/talima-therapeutics-raises-19m-for-site-specific-drugs/",
    "source_description": "Talima Therapeutics raises $19M for site-specific drugs",
    "raised_amount": 19000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 5,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "US Venture Partners",
         "permalink": "us-venture-partners",
         "image":
          {"available_sizes":
            [[[103,
               58],
              "assets/images/resized/0001/5080/15080v1-max-150x150.png"],
             [[103,
               58],
              "assets/images/resized/0001/5080/15080v1-max-250x250.png"],
             [[103,
               58],
              "assets/images/resized/0001/5080/15080v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Latterell Venture Partners",
         "permalink": "latterell-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0005/5132/55132v2-max-150x150.png"],
             [[250,
               36],
              "assets/images/resized/0005/5132/55132v2-max-250x250.png"],
             [[287,
               42],
              "assets/images/resized/0005/5132/55132v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "De Novo Ventures",
         "permalink": "de-novo-ventures",
         "image":
          {"available_sizes":
            [[[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-150x150.jpg"],
             [[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-250x250.jpg"],
             [[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 2000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 4,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "De Novo Ventures",
         "permalink": "de-novo-ventures",
         "image":
          {"available_sizes":
            [[[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-150x150.jpg"],
             [[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-250x250.jpg"],
             [[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Palo Alto Investors",
         "permalink": "palo-alto-investors",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0001/9366/19366v2-max-150x150.png"],
             [[250,
               36],
              "assets/images/resized/0001/9366/19366v2-max-250x250.png"],
             [[288,
               42],
              "assets/images/resized/0001/9366/19366v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "75 Shoreway Road ",
    "address2": "Suite C ",
    "zip_code": "94070",
    "city": "San Carlos",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.520295,
    "longitude": -122.260647}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}